Paige AI
FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research.
Paige is the specialist pick when you need regulatory-grade pathology AI rather than a general model with a medical prompt. The named assets are what matter: FDA-cleared Prostate, Breast and GI Suites, the PanCancer Suite trained on over 1.5 million slides, and a licensable foundation-model family (Virchow, Virchow2, Virchow2G, Virchow2G-Mini, PRISM) that biopharma teams can build on instead of training task-specific models from scratch. Paige Alba's voice and text copilot is the piece that changes the day-to-day workflow. Compared with open-source pathology models you'd have to validate yourself, Paige sells cleared clinical applications and regulatory strategy as a package. Compared with
Verified 18h ago · liveness 73/100 · cite: rightaichoice.com/tools/paige-ai
- Large pathology labs and health systems with high whole-slide H&E volume
- Pathologist groups looking to reduce turnaround time and workload pressure
- Biopharma companies doing biomarker discovery and clinical trial design
- Computational pathology researchers who want a licensed foundation model instead of training their own
- Radiology or non-pathology imaging workflows
- Labs whose slides are not H&E-stained
- Teams that need an open-source or open-weight pathology model they can modify freely
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Paige if your imaging work is outside cancer pathology, if your slides are not H&E-stained, or if you need an open-weight model you can inspect and retrain rather than a licensed, cleared application.
Licensing foundation models such as Virchow or PRISM is a separate commercial arrangement from the cleared clinical suites, so a diagnostic deployment does not automatically give your research team model access.
We did not reach Paige's pricing page this run, so we cannot state its tiers or rates, and we won't guess. What is clear from the product structure is that this is a specialist clinical and life-sciences platform sold alongside custom development, regulatory and commercialization services — the cost profile of a validated, FDA-cleared pathology AI plus licensed foundation models, not of a seat-based software tool. Budget accordingly: large labs and biopharma research groups are the natural fit,
In short
Paige AI — FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research. Best for Large pathology labs and health systems with high whole-slide H&E volume, Pathologist groups looking to reduce turnaround time and workload pressure, Biopharma companies doing biomarker discovery and clinical trial design. Contact Sales pricing.
No head-to-head comparison for Paige AI yet — the alternatives below are the closest matches we list.
What people actually say about Paige AI — is it worth it?
We scanned public community sources for Paige AI on Aug 6, 2026 and could not establish that the discussion we found is about this tool rather than something else sharing its name. Our own analysis of that scan says the posts were off-subject. Rather than publish a sentiment score built on the wrong subject, we publish nothing here and re-run the scan.
Viability Score
How well maintained and how widely used is Paige AI? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: October 2026
How we score →Key Features
- FDA-cleared prostate cancer detection and grading on H&E whole-slide images
- FDA-cleared breast cancer identification and classification in biopsy and excision slides
- FDA-cleared GI tract benign/malignant condition detection and classification
- Pan-cancer detection across multiple tissue types, including rare cancers
- Paige Alba multi-modal copilot with voice and text commands
- Real-time AI insights during pathology review
- Foundation models: Virchow, Virchow2, Virchow2G, Virchow2G-Mini, PRISM
- Foundation models remove the need for task-specific training
- Pre-built pan-cancer AI modules for therapeutic targeting and biomarker identification
- Clinical trial design optimization via pre-built AI modules
- OmniScreen prescreening molecular biomarker discovery directly from tissue
- OmniScreen characterization of molecular biomarkers from H&E slides
- Custom AI development, including prognostic and predictive applications
- Regulatory strategy and commercialization services
- Trained cumulatively on over 1.5 million slides
About Paige AI
Paige AI is a clinical-grade artificial intelligence platform built exclusively for cancer pathology. Its Diagnostic & Biomarker AI line provides FDA-cleared applications that assist pathologists in detecting, subtyping and grading cancer on H&E-stained whole-slide images: the Paige Prostate Suite (prostate needle biopsies), the Paige Breast Suite (breast biopsy and excision specimens), the Paige GI Suite (benign and malignant conditions across the gastrointestinal tract, built on Paige's latest foundation model work) and the Paige PanCancer Suite, which uses Virchow and was cumulatively trained on over 1.5 million slides to flag subtle cancer across multiple tissue types, including rare cancers. The same technology can reveal molecular biomarkers — such as MSI and HER2 — directly from the tissue sample rather than requiring a separate assay. Paige Alba is the company's proprietary multi-modal copilot, which takes voice and text commands to surface real-time insights inside the pathology workflow. For life sciences and biopharma, Paige licenses its foundation models (Virchow, Virchow2, Virchow2G, Virchow2G-Mini and PRISM), offers pre-built pan-cancer AI modules for therapeutic targeting, novel biomarker identification and clinical trial design, provides OmniScreen pre-screening and characterization services, and delivers custom AI development, regulatory strategy and commercialization support. Paige positions its applications as assisting rather than replacing the pathologist, aimed at reducing turnaround pressure and workload. It is a specialist vendor for labs and biopharma research groups, not a general-purpose AI tool.
Behind the Verdict
Paige's differentiation is narrower and deeper than most medical AI marketing. The clinical line is a set of cleared applications tied to specific specimen types — prostate needle biopsies, breast biopsy and excision, the GI tract — rather than one generic detector, and each is built for H&E whole-slide images, which is what most pathology labs already produce. The PanCancer Suite extends that to multiple tissue types including rare cancers, using Virchow and cumulative training on over 1.5 million slides; for a lab, that training base and the clearance record are the things you cannot assemble on your own. For life sciences buyers the offer is different and arguably more interesting: instead of a diagnostic product you license foundation models — Virchow, Virchow2, Virchow2G, Virchow2G-Mini and PRISM — plus pre-built pan-cancer modules for therapeutic targeting, biomarker identification and clinical trial design, and OmniScreen for molecular biomarker pre-screening and characterization straight from tissue. Paige explicitly frames the foundation models as removing the need for task-specific training, which is the real time and cost saving for a computational pathology team. Services wrap around all of it: custom model development including prognostic or predictive applications, regulatory strategy, and commercialization support, which matters because clearing a pathology AI application is not a research exercise. Paige Alba is the workflow play — a proprietary multi-modal copilot that accepts voice and text commands and returns real-time insights during review. Where Paige fits: large labs and health systems with high slide volume and existing whole-slide scanning, pathologist groups under turnaround pressure, and biopharma or research teams that want a validated foundation model rather than a homegrown one. Where it does not: anything outside cancer pathology, radiology or other imaging domains, labs that work primarily in stains other than H&E, and small operations with low slide volume for which a specialist clinical AI vendor is disproportionate. Foundation models are proprietary, which is a deliberate trade: you get a validated, licensed asset, not the flexibility of an open-weight model.
Researching Paige AI? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Paige AI actually fits — and what changes day-one when you adopt it.
Prostate needle biopsy cases are scanned as H&E whole-slide images and routed through the Paige Prostate Suite, with Paige Alba used to pull up findings by voice during review.
Outcome: Suspicious areas are flagged and graded before the pathologist reads the slide, so the primary read starts from a marked-up image and turnaround pressure eases.
The team licenses Virchow2G and uses the pre-built pan-cancer modules instead of training a task-specific model from scratch.
Outcome: Development time shifts from data collection and pretraining to the actual research question, and models are built on a foundation trained on over 1.5 million slides.
OmniScreen is used to pre-screen and characterise molecular biomarkers such as MSI and HER2 directly from tissue in a trial cohort.
Outcome: Biomarker signal is extracted from slides the trial already produces, informing cohort selection and clinical trial design without a separate assay workflow.
Use Cases
- Prostate cancer detection and grading on H&E needle biopsies
- Breast cancer identification and classification in biopsy and excision specimens
- GI tract benign and malignant condition detection across the gastrointestinal tract
- Pan-cancer detection spanning multiple tissue types, including rare cancers
- Molecular biomarker discovery (e.g. MSI, HER2) directly from tissue via OmniScreen
- Licensing Virchow foundation models to build custom computational pathology applications
- Custom AI model development for biopharma drug discovery and clinical trial design
- Real-time copilot assistance during pathology review using voice and text
Models Under the Hood
as of 2026-10-16
Limitations
- Paige is a specialist clinical AI vendor focused on cancer pathology on H&E-stained whole-slide images, so radiology, other imaging domains and non-H&E staining workflows are out of scope.
- The foundation models — Virchow, Virchow2, Virchow2G, Virchow2G-Mini and PRISM — are proprietary and licensed, limiting the freedom of researchers who want open-weight models they can inspect and retrain.
- The clinical line is delivered as cleared applications (e.g.
- Paige Prostate Suite, Paige Breast Suite), so adoption is tied to cleared specimen types and indications rather than ad-hoc use.
- We did not reach the docs or integrations pages this run, so we make no claims about API availability, connector coverage or scanner and LIS compatibility.
as of 2026-09-30
Verification history
We have re-verified Paige AI 21 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
Showing the 6 most recent of 21 verification passes.
Free to cite with attribution — this page re-verifies continuously.
Where the pricing makes sense
The company stage and team size where Paige AI's pricing actually pencils out — and where peers do it cheaper.
We did not reach Paige's pricing page this run, so we cannot state its tiers or rates, and we won't guess. What is clear from the product structure is that this is a specialist clinical and life-sciences platform sold alongside custom development, regulatory and commercialization services — the cost profile of a validated, FDA-cleared pathology AI plus licensed foundation models, not of a seat-based software tool. Budget accordingly: large labs and biopharma research groups are the natural fit,
Setup time & first value
How long it actually takes to get something useful out of Paige AI — broken out by persona, not the marketing-page minute.
Expect a project rather than an afternoon. Clinical deployment means digitising H&E slides into whole-slide images, validating the suite against your specimen mix, and fitting it into the existing read workflow — a process run with Paige rather than self-served. Research teams licensing Virchow models start faster because there is no clearance step, with first value coming once your slide data is
Switching to or from Paige AI
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From open-source pathology models: replace self-validated pipelines with FDA-cleared Prostate, Breast and GI Suites plus licensed Virchow foundation models.
- ↗To an open-weight pathology model: move off licensed Virchow and PRISM models if you need to inspect, retrain and host the model yourself, accepting that you take on validation.
Resources & Guides
- Resourcepaige.ai
How Foundation Models Can Transform Pathology — Paige.ai
Helpful link from paige.ai
- Resourcepaige.ai
Transforming Drug Discovery and Scientific Innovation with Foundation Model Technology — Paige.ai
Helpful link from paige.ai
- Resourcepaige.ai
Breaking Through the Complexity of Cancer Detection — Paige.ai
Helpful link from paige.ai
- Resourcepaige.ai
Embracing AI: The Third Revolution in Pathology — Paige.ai
Helpful link from paige.ai
- Resourcepaige.ai
The State of Digital Pathology and AI in 2024 — Paige.ai
Helpful link from paige.ai
- Resourcepaige.ai
The Virchow Foundation Model, Explained: A Q&A with an AI Scientist — Paige.ai
Helpful link from paige.ai
Tutorials & Learning
YouTube returned 6 videos for “Paige AI”, and we withheld 6: 6 could not be judged, because “Paige AI” is a single word that other videos use for other things. We are showing none, because we could not prove any of them are about Paige AI.
Official links
Tools that pair well with Paige AI
Common stack mates teams adopt alongside Paige AI, with the specific reason each pairing earns its keep.
Quibim
Quibim turns MRI, CT and PET scans into regulatory-cleared quantitative imaging biomarkers for prostate, brain, liver, breast and lung.
Flatiron Health
Oncology real-world evidence platform combining high-fidelity patient data with AI-assisted cancer research insights.
Verge Genomics
All-in-human AI foundation models for precision neurology — vBx-1.0 predicts brain activity and therapy response from a blood draw.
Alternatives to Paige AI
View all
Quibim
Quibim turns MRI, CT and PET scans into regulatory-cleared quantitative imaging biomarkers for prostate, brain, liver, breast and lung.
Flatiron Health
Oncology real-world evidence platform combining high-fidelity patient data with AI-assisted cancer research insights.
Verge Genomics
All-in-human AI foundation models for precision neurology — vBx-1.0 predicts brain activity and therapy response from a blood draw.
Frequently Asked Questions
Used Paige AI? Help shape our editorial sentiment research.